Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells.
暂无分享,去创建一个
[1] Roland Martin,et al. The immunopathogenesis of multiple sclerosis. , 2002, Journal of rehabilitation research and development.
[2] S. Miller,et al. Direct Activation of Innate and Antigen-Presenting Functions of Microglia following Infection with Theiler's Virus , 2001, Journal of Virology.
[3] H. Lipton,et al. High Numbers of Viral RNA Copies in the Central Nervous System of Mice during Persistent Infection with Theiler's Virus , 2001, Journal of Virology.
[4] H. Lipton,et al. UDP-galactose transporter is required for Theiler's virus entry into mammalian cells. , 2001, Virology.
[5] J. Platt,et al. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. , 1999, Journal of immunology.
[6] S. Miller,et al. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. , 1998, Journal of immunology.
[7] S. Zamvil,et al. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells , 1998, Journal of Neuroimmunology.
[8] L. Adorini,et al. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. , 1998, Journal of immunology.
[9] L. Matis,et al. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. , 1998, Journal of immunology.
[10] J. Ting,et al. Identification of Distinct Regions of 5′ Flanking DNA That Mediate Constitutive, IFN-γ, STAT1, and TGF-β-Regulated Expression of the Class II Transactivator Gene , 1998, The Journal of Immunology.
[11] N. Rothwell. Immune responses in the nervous system , 1997 .
[12] T. Mak,et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. , 1997, Immunity.
[13] B. Mach,et al. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.
[14] R. Ransohoff,et al. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. , 1997, Journal of immunology.
[15] K. Gordon,et al. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. , 1997, Journal of immunology.
[16] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[17] R. Lechler,et al. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells , 1996, The Journal of experimental medicine.
[18] K. Okumura,et al. CD86 (B70/B7-2) on endothelial cells co-stimulates allogeneic CD4+ T cells. , 1995, International immunology.
[19] M. Croft,et al. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. , 1995, Journal of immunology.
[20] A. Strosberg,et al. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin‐1 , 1995, European journal of immunology.
[21] S. Miller,et al. Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases , 1995, Immunological reviews.
[22] R. Flavell,et al. Class II transactivator regulates the expression of multiple genes involved in antigen presentation , 1995, The Journal of experimental medicine.
[23] P. Linsley,et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. , 1995, Journal of immunology.
[24] Y. Lee,et al. Characterization of astrocyte nuclear proteins involved in IFN-gamma- and TNF-alpha-mediated class II MHC gene expression. , 1994, Journal of immunology.
[25] R. Flavell,et al. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes , 1994, The Journal of experimental medicine.
[26] B. Mach,et al. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.
[27] J. Bluestone,et al. The B7 and CD28 receptor families. , 1994, Immunology today.
[28] P. Linsley,et al. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. , 1994, Journal of immunology.
[29] D. Montgomery,et al. Astrocytes: Form, Functions, and Roles in Disease , 1994, Veterinary pathology.
[30] B. Mach,et al. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.
[31] Roger D. Smith,et al. Correlation between susceptibility to demyelination and interferon-γ induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells , 1993, Journal of Neuroimmunology.
[32] Y. Ron,et al. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. , 1993, Journal of immunology.
[33] M. Hart,et al. Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. , 1993, Journal of immunology.
[34] M. Eddleston,et al. Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.
[35] P. Linsley,et al. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. , 1993, Cellular immunology.
[36] B. Fleischer,et al. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens. , 1993, Journal of immunology.
[37] S. Miller,et al. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein , 1992, Journal of Neuroimmunology.
[38] P. Linsley,et al. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. , 1992, Journal of immunology.
[39] P. Marrack,et al. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[40] A. Cross,et al. Anti—tumor necrosis factor therapy abrogates autoimmune demyelination , 1991, Annals of neurology.
[41] Y. Shimamoto,et al. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats , 1991, Journal of Neuroimmunology.
[42] Klaus Rajewsky,et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.
[43] E. Benveniste,et al. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains , 1991, The Journal of experimental medicine.
[44] C. Brosnan,et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.
[45] C. Jacob,et al. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. , 1991, Journal of immunology.
[46] W. Hickey,et al. T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.
[47] D. Willenborg,et al. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation , 1990, Journal of the Neurological Sciences.
[48] V. ter meulen,et al. Antigen-specific damage to brain vascular endothelial cells mediated by encephalitogenic and nonencephalitogenic CD4+ T cell lines in vitro. , 1990, Journal of immunology.
[49] R. Clark,et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.
[50] R. McCarron,et al. The inhibitory effect of tumor necrosis factor and interleukin-1 on Ia induction by interferon-γ on endothelial cells from murine central nervous system microvessels , 1990, Journal of Neuroimmunology.
[51] B. Engelhardt,et al. Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro , 1990, The Journal of cell biology.
[52] D. McFarlin,et al. Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope. , 1989, Journal of immunology.
[53] D. Willoughby,et al. Presentation of myelin basic protein by normal guinea-pig brain endothelial cells and its relevance to experimental allergic encephalomyelitis. , 1989, Immunology.
[54] G. Pryce,et al. Antigen presentation in brain: brain endothelial cells are poor stimulators of T-cell proliferation. , 1989, Immunology.
[55] G. Pryce,et al. Induction of Ia molecules on brain endothelium is related to susceptibility to experimental allergic encephalomyelitis , 1989, Journal of Neuroimmunology.
[56] G. Wong,et al. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. , 1988, Journal of immunology.
[57] D. Mason,et al. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system , 1987, The Journal of experimental medicine.
[58] H. Lassmann,et al. Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.
[59] R. McCarron,et al. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. , 1986, Journal of immunology.
[60] H. Wekerle,et al. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes , 1986, Nature.
[61] R. McCarron,et al. Presentation of myelin basic protein by murine cerebral vascular endothelial cells. , 1985, Journal of immunology.
[62] B. Arnason. Relevance of experimental allergic encephalomyelitis to multiple sclerosis. , 1983, Neurologic clinics.
[63] R. Hughes,et al. Immunology of the Nervous System , 1983 .
[64] J. Longmire,et al. Isolation of a B-cell-specific promoter for the human class II transactivator , 1997, Immunogenetics.
[65] J. Banchereau,et al. CD40-CD40 ligand: a multifunctional receptor-ligand pair. , 1996, Advances in immunology.
[66] M. Yacoub,et al. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. , 1996, Immunology.
[67] P. Knopf,et al. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. , 1992, Immunology today.
[68] Y. Shimamoto,et al. Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. , 1991, Journal of neuroimmunology.
[69] G. Pryce,et al. Kinetics of MHC gene expression and mRNA synthesis in brain endothelium. , 1988, Immunology.